Soditic Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $10.6M | Hold |
31,727
| – | – | 10.79% | 4 |
|
|
2024
Q2 | $8.66M | Hold |
31,727
| – | – | 10.04% | 4 |
|
|
2024
Q1 | $11M | Sell |
31,727
-5,392
| -15% | -$1.86M | 13% | 4 |
|
|
2023
Q4 | $12M | Sell |
37,119
-556
| -1% | -$180K | 8.71% | 5 |
|
|
2023
Q3 | $13.5M | Hold |
37,675
| – | – | 10.4% | 4 |
|
|
2023
Q2 | $14.3M | Buy |
37,675
+15,425
| +69% | +$5.85M | 10.42% | 4 |
|
|
2023
Q1 | $10.7M | Buy |
22,250
+810
| +4% | +$388K | 11.8% | 3 |
|
|
2022
Q4 | $9.02M | Buy |
21,440
+1,710
| +9% | +$719K | 11.16% | 4 |
|
|
2022
Q3 | $8.23M | Hold |
19,730
| – | – | 10.26% | 4 |
|
|
2022
Q2 | $9.77M | Buy |
19,730
+3,250
| +20% | +$1.61M | 7.5% | 6 |
|
|
2022
Q1 | $9.28M | Hold |
16,480
| – | – | 5.49% | 9 |
|
|
2021
Q4 | $12.5M | Hold |
16,480
| – | – | 6.42% | 9 |
|
|
2021
Q3 | $12.3M | Hold |
16,480
| – | – | 5.82% | 10 |
|
|
2021
Q2 | $10.6M | Hold |
16,480
| – | – | 5.36% | 10 |
|
|
2021
Q1 | $9.41M | Buy |
16,480
+7,560
| +85% | +$4.32M | 4.84% | 11 |
|
|
2020
Q4 | $5.2M | Buy |
+8,920
| New | +$5.2M | 5.18% | 10 |
|